"RXRX is a high-upside AI drug-manufacturing pure-play with multiple forthcoming clinical readouts (he cites 10 readouts), and he argues that even a small subset succeeding could drive massive value creation versus its current “cheap” valuation."
"These 2 Stocks Will Make Me A Billionaire by 2028! NASDAQ: RXRX, LON: POLB!"